NCT05522387 2026-02-27
An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease
Inmune Bio, Inc.
Phase 2 Terminated
Inmune Bio, Inc.
Palleos Healthcare GmbH
Centre Hospitalier Universitaire de Besancon
Samus Therapeutics, Inc.
Nouvelle Clinique Bonnefon